Rationally designed tularemia vaccines

References

• Tarnvik A, Berglund L. Tularaemia. Eur. Respir. J.21(2), 361–373 (2003).
   PubMed Web of Science ®Google Scholar
• Eliasson H, Broman T, Forsman M, Back E. Tularemia: current epidemiology and disease management. Infect. Dis. Clin. North Am.20, 289–311 (2006).
   PubMed Web of Science ®Google Scholar
• Johansson A, Farlow J, Larsson P et al. Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis. J. Bacteriol.186(17), 5808–5818 (2004).
   PubMed Web of Science ®Google Scholar
• Broekhuijsen M, Larsson P, Johansson A et al. Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis.J. Clin. Microbiol.41(7), 2924–2931 (2003).
   PubMed Web of Science ®Google Scholar
• Rohmer L, Brittnacher M, Svensson K et al. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Infect. Immun.74(12), 6895–6906 (2006).
   PubMed Web of Science ®Google Scholar
• Petrosino JF, Xiang Q, Karpathy SE et al. Chromosome rearrangement and diversification of Francisella tularensis revealed by the type B (OSU18) genome sequence. J. Bacteriol.188(19), 6977–6985 (2006).
   PubMed Web of Science ®Google Scholar
• Rohmer L, Fong C, Abmayr S et al. Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol.8(6), R102 (2007).
   PubMed Web of Science ®Google Scholar
• Conlan JW, Oyston PC. Vaccines against Francisella tularensis.Ann. NY Acad. Sci.1105, 325–350 (2007).
   PubMed Web of Science ®Google Scholar
• Hornick RB, Eigelsbach HT. Aerogenic immunization of man with live tularemia vaccine. Bacteriol. Rev.30(3), 532–538 (1966).
   PubMedGoogle Scholar
• Conlan JW, North RJ. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun.60(12), 5164–5171 (1992).
   PubMed Web of Science ®Google Scholar
• Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ, Furie MB. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J. Immunol.171(5), 2563–2570 (2003).
   PubMed Web of Science ®Google Scholar
• Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjostedt A. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect. Immun.71(10), 5940–5950 (2003).
   PubMed Web of Science ®Google Scholar
• Clemens DL, Lee BY, Horwitz MA. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun.72(6), 3204–3217 (2004).
   PubMed Web of Science ®Google Scholar
• Conlan JW, Shen H, Kuolee R, Zhao X, Chen W. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an αβ T cell- and interferon γ-dependent mechanism. Vaccine23(19), 2477–2485 (2005).
   PubMed Web of Science ®Google Scholar
• Elkins KL, Cowley SC, Bosio CM. Innate and adaptive immunity to Francisella.Ann. NY Acad. Sci.1105, 284–324 (2007).
   PubMed Web of Science ®Google Scholar
• Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.J. Immunol.179(1), 532–539 (2007).
   PubMed Web of Science ®Google Scholar
• Baron SD, Singh R, Metzger DW. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect. Immun.75(5), 2152–2162 (2007).
   PubMed Web of Science ®Google Scholar
• Sebastian S, Pinkham JT, Lynch JG et al. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.Vaccine27(4), 597–605 (2009).
   PubMed Web of Science ®Google Scholar
• Van Metre TJ, Kadull P. Laboratory-acquired tularemia in vaccinated individuals: a report of 62 cases. Ann. Intern. Med.50, 621–632 (1959).
   PubMed Web of Science ®Google Scholar
• Eigelsbach HT, Downs CM. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J. Immunol.87, 415–425 (1961).
   PubMed Web of Science ®Google Scholar
• Qin A, Mann BJ. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol.6, 69 (2006).
   PubMed Web of Science ®Google Scholar
• Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR. Genome-wide identification of Francisella tularensis virulence determinants. Infect. Immun.75(6), 3089–3101 (2007).
   PubMed Web of Science ®Google Scholar
• Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl Acad. Sci. USA104(14), 6037–6042 (2007).
   PubMed Web of Science ®Google Scholar
• Tempel R, Lai XH, Crosa L, Kozlowicz B, Heffron F. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect. Immun.74(9), 5095–5105 (2006).
   PubMed Web of Science ®Google Scholar
• Maier TM, Casey MS, Becker RH et al. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect. Immun.75(11), 5376–5389 (2007).
   PubMed Web of Science ®Google Scholar
• Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect. Immun.74(8), 4452–4461 (2006).
   PubMed Web of Science ®Google Scholar
• Pechous RD, McCarthy TR, Mohapatra NP et al. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE3(6), e2487 (2008).
   PubMed Web of Science ®Google Scholar
• Bakshi CS, Malik M, Mahawar M et al. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine26(41), 5276–5288 (2008).
   PubMed Web of Science ®Google Scholar
• Bakshi CS, Malik M, Regan K et al. Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence. J. Bacteriol.188(17), 6443–6448 (2006).
   PubMed Web of Science ®Google Scholar
• Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS et al. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Microbiology.153(Pt 9), 3141–3153 (2007).
   PubMed Web of Science ®Google Scholar
• Conlan JW, Shen H, Webb A, Perry MB. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine20(29–30), 3465–3471 (2002).
   PubMed Web of Science ®Google Scholar
• Fulop M, Mastroeni P, Green M, Titball RW. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.Vaccine19(31), 4465–4472 (2001).
   PubMed Web of Science ®Google Scholar
• Jackson M, Phalen SW, Lagranderie M et al. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect. Immun.67(6), 2867–2873 (1999).
   PubMed Web of Science ®Google Scholar
• Sebastian S, Dillon ST, Lynch JG et al. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect. Immun.75(5), 2591–2602 (2007).
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Pasetti MF, Barry EM et al. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a Phase 1 trial of CVD 1204 and CVD 1208. J. Infect. Dis.190(10), 1745–1754 (2004).
   PubMed Web of Science ®Google Scholar
• Wang JY, Pasetti MF, Noriega FR et al. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar typhi strain CVD 915. Infect. Immun.69(8), 4734–4741 (2001).
   PubMed Web of Science ®Google Scholar
• Shen H, Chen W, Conlan JW. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.Microb. Pathog.37(2), 107–110 (2004).
   PubMed Web of Science ®Google Scholar
• Quarry JE, Isherwood KE, Michell SL, Diaper H, Titball RW, Oyston PC. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Vaccine25(11), 2011–2018 (2007).
   PubMed Web of Science ®Google Scholar
• Kanistanon D, Hajjar AM, Pelletier MR et al. A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog.4(2), e24 (2008).
   PubMed Web of Science ®Google Scholar
• Pammit MA, Raulie EK, Lauriano CM, Klose KE, Arulanandam BP. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect. Immun.74(4), 2063–2071 (2006).
   PubMed Web of Science ®Google Scholar
• Santic M, Molmeret M, Klose KE, Jones S, Kwaik YA. The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell. Microbiol.7(7), 969–979 (2005).
   PubMed Web of Science ®Google Scholar
• Lai XH, Golovliov I, Sjostedt A. Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis.Microb. Pathog.37(5), 225–230 (2004).
   PubMed Web of Science ®Google Scholar
• Twine S, Bystrom M, Chen W et al. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect. Immun.73(12), 8345–8352 (2005).
   PubMed Web of Science ®Google Scholar
• Qin A, Scott DW, Mann BJ. Francisella tularensis Schu S4 disulfide bond formation protein B, (DsbB), but not an RND-type efflux pump, is required for virulence. Infect. Immun.76(7), 3086–3092 (2008).
   PubMed Web of Science ®Google Scholar
• Qin A, Scott DW, Thompson JA, Mann BJ. Identification of an essential Francisella tularensis subsp. tularensis virulence factor. Infect. Immun.77(1), 152–161 (2009).
   PubMed Web of Science ®Google Scholar
• Huntley JF, Conley PG, Rasko DA, Hagman KE, Apicella MA, Norgard MV. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.Infect. Immun.76(8), 3664–3671 (2008).
   PubMed Web of Science ®Google Scholar
• Roland KL, Tinge SA, Killeen KP, Kochi SK. Recent advances in the development of live, attenuated bacterial vectors. Curr. Opin. Mol. Ther.7(1), 62–72 (2005).
   PubMedGoogle Scholar
• Kopecko DJ, Sieber H, Ures JA et al. Genetic stability of vaccine strain Salmonella typhi Ty21a over 25 years. Int. J. Med. Microbiol.299(4), 233–246 (2008).
   Web of Science ®Google Scholar
• Fulop M, Manchee R, Titball R. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence. FEMS Immunol. Med. Microbiol.13(3), 245–247 (1996).
   PubMedGoogle Scholar
• Sjostedt A, Sandstrom G, Tarnvik A. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium.Infect. Immun.60(7), 2855–2862 (1992).
   PubMed Web of Science ®Google Scholar
• Jia Q, Lee BY, Clemens DL, Bowen RA, Horwitz MA. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized type A F. tularensis.Vaccine 27(8), 1216–1229 (2009).
   PubMed Web of Science ®Google Scholar
• Bruhn KW, Craft N, Miller JF. Listeria as a vaccine vector. Microbes Infect.9(10), 1226–1235 (2007).
   PubMed Web of Science ®Google Scholar
• Kim SH, Castro F, Gonzalez D, Maciag PC, Paterson Y, Gravekamp C. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. Br. J. Cancer.99(5), 741–749 (2008).
   PubMed Web of Science ®Google Scholar
• Angelakopoulos H, Loock K, Sisul DM, Jensen ER, Miller JF, Hohmann EL. Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect. Immun.70(7), 3592–3601 (2002).
   PubMed Web of Science ®Google Scholar
• Chen W, Shen H, Webb A, KuoLee R, Conlan JW. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine21(25–26), 3690–3700 (2003).
   PubMed Web of Science ®Google Scholar